Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memory Impairment Study
NCT00000173Phase 3Completed
- Sponsor
- National Institute on Aging
- Start
- Mar 1999
- Primary completion
- Jan 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Alzheimer's disease (AD) comparing Placebo, Vitamin E and Donepezil (3 arms). Primary endpoint: Time to development of Probable or Possible AD at 3 years. Started Mar 1999; status: completed.
02
Drugs
donepezilvitamin e
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00000173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000173.